CN102281894A - 睡眠中呼吸努力相关觉醒和打鼾的治疗以及药剂 - Google Patents

睡眠中呼吸努力相关觉醒和打鼾的治疗以及药剂 Download PDF

Info

Publication number
CN102281894A
CN102281894A CN2009801544382A CN200980154438A CN102281894A CN 102281894 A CN102281894 A CN 102281894A CN 2009801544382 A CN2009801544382 A CN 2009801544382A CN 200980154438 A CN200980154438 A CN 200980154438A CN 102281894 A CN102281894 A CN 102281894A
Authority
CN
China
Prior art keywords
subject
experimenter
snoring
staphylococcus aureus
immunostimulant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801544382A
Other languages
English (en)
Chinese (zh)
Inventor
菲利普.科曼斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008905902A external-priority patent/AU2008905902A0/en
Application filed by Individual filed Critical Individual
Publication of CN102281894A publication Critical patent/CN102281894A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN2009801544382A 2008-11-13 2009-11-09 睡眠中呼吸努力相关觉醒和打鼾的治疗以及药剂 Pending CN102281894A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2008905902A AU2008905902A0 (en) 2008-11-13 Treatment for snoring and respiratory effort related arousals in sleep
AU2008905902 2008-11-13
PCT/AU2009/001451 WO2010054424A1 (en) 2008-11-13 2009-11-09 Agents and treatment for snoring and respiratory effort related arousals in sleep

Publications (1)

Publication Number Publication Date
CN102281894A true CN102281894A (zh) 2011-12-14

Family

ID=42169525

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009801544382A Pending CN102281894A (zh) 2008-11-13 2009-11-09 睡眠中呼吸努力相关觉醒和打鼾的治疗以及药剂

Country Status (8)

Country Link
US (1) US20110311588A1 (enExample)
EP (1) EP2358385A4 (enExample)
JP (2) JP2012508693A (enExample)
KR (1) KR20110112803A (enExample)
CN (1) CN102281894A (enExample)
AU (1) AU2009316226B2 (enExample)
CA (1) CA2743649A1 (enExample)
WO (1) WO2010054424A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115644136A (zh) * 2022-11-11 2023-01-31 河南省人民医院 一种用于阻塞性呼吸睡眠暂停综合征的微生态动物模型

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8387798B1 (en) 2012-04-27 2013-03-05 Abdulmohsen E. A. H. Al-Terki Mutiple oral and nasal surgical procedures method and kit
US10022083B2 (en) 2011-06-02 2018-07-17 Abdulmohsen E. A. H. Al-Terki Multiple oral and nasal surgical procedures method and kit
US11406671B2 (en) 2015-04-24 2022-08-09 The Translational Genomics Research Institute Compositions and methods for augmenting the nasal microbiome
CN113943679B (zh) * 2021-11-08 2023-02-03 南京农业大学 一株羊鼻腔源贝莱斯芽孢杆菌及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
SE9604844D0 (sv) * 1996-12-30 1996-12-30 Carl Gerhard Gottfries Medel för terapeutisk behandling av fibromyalgi och kroniskt trötthetssyndrom

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115644136A (zh) * 2022-11-11 2023-01-31 河南省人民医院 一种用于阻塞性呼吸睡眠暂停综合征的微生态动物模型
CN115644136B (zh) * 2022-11-11 2025-07-29 河南省人民医院 一种用于阻塞性呼吸睡眠暂停综合征的微生态动物模型

Also Published As

Publication number Publication date
CA2743649A1 (en) 2010-05-20
EP2358385A4 (en) 2013-08-14
US20110311588A1 (en) 2011-12-22
WO2010054424A1 (en) 2010-05-20
JP2012508693A (ja) 2012-04-12
JP2015180689A (ja) 2015-10-15
AU2009316226A1 (en) 2010-05-20
EP2358385A1 (en) 2011-08-24
AU2009316226B2 (en) 2015-08-13
KR20110112803A (ko) 2011-10-13

Similar Documents

Publication Publication Date Title
Pregliasco et al. A new chance of preventing winter diseases by the administration of synbiotic formulations
Gill Probiotics to enhance anti-infective defences in the gastrointestinal tract
TWI494114B (zh) 鼠李醣乳酸桿菌gg(lgg)於治療、預防或減輕全身性發炎之用途
US20060177424A1 (en) Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
CN104093412B (zh) 用于制备治疗或预防过敏性疾病的药物的用途
JP2009269925A (ja) Ｓｉｄｓに関連する細菌感染を処置するための共生乳酸細菌
JP5896589B2 (ja) 疾病の罹患率及び持続期間を減少する使用のためのプロバイオティクス
ES2399775T3 (es) Composiciones farmacéuticas que comprenden L. acidophilus y bifidobacterium lactis para el uso en el tratamiento de un trastorno intestinal funcional
JP2015180689A (ja) 睡眠中の鼾および呼吸努力関連覚醒のための薬および処置
Susanti et al. Asthma clinical improvement and reduction in the number of CD4 CD25 foxp3 Treg and CD4 IL-10 cells after administration of immunotherapy house dust mite and adjuvant probiotics and/or Nigella Sativa powder in mild asthmatic children
JP2007169200A (ja) インフルエンザ感染予防のための医薬及び飲食品
WO2007133188A1 (en) Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
JPH09263539A (ja) 抗真菌作用を有する皮膚疾患治療剤
Banik et al. Efficacy of Lactobacillus reuteri in improving gut barrier function & management of infantile colic
Bal et al. Vaginal and rectal delivery of probiotics
US11020440B2 (en) Probiotic for the treatment of psoriasis
El-Ansary et al. Gut-lung cross talk in COVID-19 pathology and fatality rate
CN120000694A (zh) 一种用于缓解呼吸道不适的组合物及其应用和产品
Jamie Oskin et al. Supporting Children’s ENT and Immune Health Through the Oral Microbiome
CN119752686A (zh) 一株可缓解及预防变应性鼻炎的长双歧杆菌婴儿亚种及其应用
HK1136969B (en) Product containing inactivated probiotic for infants
HK1146914B (en) Pharmaceutical compositions comprising l. acidophilus and bifidobacterium lactis for use in the treatment of functional bowel disorder

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20111214